Action of Reverse T3 on Cancer Cells

Hung Yun Lin, Heng Yuan Tang, Matthew Leinung, Shaker A. Mousa, Aleck Hercbergs, Paul J. Davis

研究成果: 雜誌貢獻文章

3 引文 斯高帕斯(Scopus)

摘要

Background: Reverse T3 (rT3; 3,3',5'-triiodo-L-thyronine) is widely regarded as an inactive naturally occurring analog of thyroid hormone. rT3 is known to bind to the thyroid hormone analog receptor on plasma membrane integrin αvβ3. This integrin is generously expressed by tumor cells and is the initiation site for the stimulation by L-thyroxine (T4) at physiological free concentrations on cancer cell proliferation. Results: In the present studies, we show that rT3 caused increases of proliferation in vitro of 50% to 80% (P < 0.05–0.001) of human breast cancer and glioblastoma cells. Conclusion: rT3 may be a host factor supporting cancer growth.
原文英語
期刊Endocrine Research
DOIs
出版狀態已發佈 - 一月 1 2019

ASJC Scopus subject areas

  • Endocrinology

指紋 深入研究「Action of Reverse T3 on Cancer Cells」主題。共同形成了獨特的指紋。

  • 引用此

    Lin, H. Y., Tang, H. Y., Leinung, M., Mousa, S. A., Hercbergs, A., & Davis, P. J. (2019). Action of Reverse T3 on Cancer Cells. Endocrine Research. https://doi.org/10.1080/07435800.2019.1600536